Four things to know:
1. Conformis entered into a licensing agreement for its patient-specific joint replacement instrumentation technology with Stryker. Stryker paid $14 million upfront, and could make up to $16 million in additional payments upon achieving certain milestones.
2. With this agreement, the companies will collaborate to design, manufacture and commercialize patient-specific instrumentation for use with Stryker’s knee offerings, including the Triathlon total knee system.
3. The two companies also entered into a distribution agreement for Conformis to provide Stryker with patient-specific instrumentation. Conformis retains all IP for patient-specific implants.
4. Conformis’ proprietary technology uses a CT-based 3D model to create disposable instrumentation for joint replacement procedures.
Editors Note: This article was updated at 4:25 pm CST to reflect that Stryker entered into a licensing agreement for patient-specific instrumentation, not patient-specific implants. Conformis will retain all IP for patient-specific implants.
More articles on orthopedics:
NuVasive aims to grow in robotics with new application
Zimmer Biomet adds to leadership ranks
Brainlab unveils mobile intraoperative robot for spine surgery
